Drug Royalty Corp., TPL Phytogen Inc., Peptide, Dura deal

DRI will provide C$1.5 million to further TPL's development of paclitaxel, a naturally occurring cancer compound

Read the full 166 word article

How to gain access

Continue reading with a
two-week free trial.